Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
about
IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cellsPUMA, a potent killer with or without p53Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas.CXCL12 chemokine expression and secretion regulates colorectal carcinoma cell anoikis through Bim-mediated intrinsic apoptosis.PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosisRegorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis.Impact of the Bim Deletion Polymorphism on Survival Among Patients With Completely Resected Non-Small-Cell Lung CarcinomaExpression of Bim, Noxa, and Puma in non-small cell lung cancerThe Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment.Bim and Bmf in tissue homeostasis and malignant disease.Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinomaThe Globalization of Cooperative Groups.PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiformeBcl2 family proteins in carcinogenesis and the treatment of cancer.Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells.Noxa: at the tip of the balance between life and death.BH3-only proteins and their effects on cancer.Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biology.Multimodal treatment strategies for locally advanced rectal cancer.A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.Nanopreparations to overcome multidrug resistance in cancer.The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer.Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells.Prognostic factors assessed for 15,096 patients with colon cancer in stages I and II.Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance.Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.The fundamental role of miR-10b in metastatic cancer
P2860
Q24310103-121BE429-D459-42BC-BC3F-BE86C59FA23AQ24631776-7464A502-D6A9-406B-BAA4-407B74FE0220Q31081979-B58FB5D0-F209-4814-80A9-9A0AB44E56BDQ33705126-73AB9266-DB0B-40F0-B127-6E83C601B6D3Q33785941-EE654D30-CCB3-4153-B0E7-65FDC31E7020Q33838524-5EE79BF8-81EB-4987-8EE2-60398B6739F0Q33873206-F7A023D5-261E-493C-8C8D-0231594E5EAFQ34334492-EBA9A31C-C16B-452B-8D10-CCA73AB0728EQ35180339-D78E3EAF-C702-44F0-8876-35B832DA8646Q35737865-7B63D5A0-893B-4617-95F6-CE6DDD6E77ECQ35832569-BB34C0ED-7CAC-4E4B-BA4D-76E391A5CEE4Q36119749-2838A77C-97A2-4127-BD01-3DBE38172DD6Q36252554-2D41C09A-0E4B-4078-A8C2-CFB71A11053CQ36525099-CA882E15-F1F6-43BA-AFBB-F076E2A856E9Q37373448-65B2032D-0419-46D6-A410-9DD919F63EA5Q37564773-63D87D5B-66AA-499B-A9BD-FF1049BDCAA1Q37566236-2E5C7763-FF04-474B-83B1-B59BB58A1BA0Q37797387-3DB32727-CBC9-45EA-8B6B-02F3A4DFF255Q37883974-03954D6C-B7B6-494D-B9C2-0231FAAC40F8Q38002470-D70FE3F8-82E8-475F-B1D8-853A14E45C47Q38061861-E6E1995D-1904-477E-ACE2-E380CB280FC2Q38131264-F8123A69-098E-4ED3-84BD-17FBE4BCC86DQ38157864-ECFD7658-8495-48F7-8C41-377376CD3010Q39009610-111C3707-DECD-4CFF-9BCD-B1D2B2C09ECDQ39480964-BD84C78B-E935-4A76-BC5C-BC7CDDB3F57EQ40066192-0F39C9E7-9F7E-4928-A2FC-9D8B81174B41Q40985170-3F48AFFD-FA23-44CC-B7C6-97BDB2971D46Q45385608-EF78F251-9DD0-48F4-AC10-490071A05021Q50170757-CE06F752-623D-4B21-88CD-1C44FFCA2D5CQ50173842-D76171A6-2D23-4FB6-974E-7AFCE32BF4D1Q54324873-7E2C149D-D7EB-4AC7-9DF6-B114447DB383Q57494141-CE180591-8298-4671-9E41-549E42886E0B
P2860
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@ast
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@en
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@nl
type
label
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@ast
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@en
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@nl
prefLabel
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@ast
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@en
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
@nl
P2093
P2860
P1476
Prognostic impact of bim, puma, and noxa expression in human colon carcinomas
@en
P2093
Frank A Sinicrope
Harold E Windschitl
Kenji Okumura
Michael J O'Connell
Nathan R Foster
Rafaela L Rego
P2860
P304
P356
10.1158/1078-0432.CCR-07-5202
P407
P577
2008-09-01T00:00:00Z